Brainsway Ltd. files 20-F

BrainsWay Ltd. reported a net profit of $7.6 million for the fiscal year ended December 31, 2025, an increase from $2.9 million in 2024, driven by increased sales and leases of its Deep TMS systems. The company also expanded its FDA clearances for Deep TMS to include accelerated treatment protocols and adolescent patients for Major Depressive Disorder (MDD), and made strategic minority investments in Management Service Organizations (MSOs) and Neurolief. (2) Key Points: